Ch04.3Tutorial

Ch04.3Tutorial - Engineered Antibodies/Therapeutic...

Info iconThis preview shows pages 1–32. Sign up to view the full content.

View Full Document Right Arrow Icon
Appendix: Antibody and T-cell based Technologies MBB/HSCI 426; Immune System I Tutorials 26-29 September 2011 Taken from: Appendix, pp. 723-752
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Antibody-based Assays Appendix, pp. 723-739
Background image of page 2
Figure A-6
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Figure A-39 Antigen Microarrays & Antibody Microarrays
Background image of page 4
Figure A-7
Background image of page 5

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Figure A-11
Background image of page 6
Figure A-34
Background image of page 7

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Figure A-14 Hybridoma Technology: A source of antigen-specific monoclonal antibodies (MAbs)
Background image of page 8
Background image of page 9

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 10
Ollman-Saphire et al. , submitted
Background image of page 11

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Ollman-Saphire et al. , submitted
Background image of page 12
Figure A-15
Background image of page 13

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
scFv Fd (e.g., llama antibodies) Fusions (e.g., toxin fused to a scFv) bifunctional Abs
Background image of page 14
Background image of page 15

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 16
Background image of page 17

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 18
Background image of page 19

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 20
Background image of page 21

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 22
Background image of page 23

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 24
Background image of page 25

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 26
Background image of page 27

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 28
Background image of page 29

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 30
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Engineered Antibodies/Therapeutic Antibodies Figure A-31 Figure A-5 Figure A-26 Figure A-29 Antibodies can be used to affinity-purify antigens for further analysis, such as 2-D gel electrophoresis of fragmented antigen Fluorescently Labeled Antibodies Serve Multiple Purposes Immunofluorescent Microscopy Multiple Markers Can Discriminate Among Cell Types Flow Cytometry & Fluorescence Activated Cell Sorting (FACS) Figure A-25 part 2 of 2 T-cell based Assays Appendix, pp. 739-752...
View Full Document

This note was uploaded on 11/05/2011 for the course MBB 426 taught by Professor Scott during the Spring '11 term at Simon Fraser.

Page1 / 32

Ch04.3Tutorial - Engineered Antibodies/Therapeutic...

This preview shows document pages 1 - 32. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online